ClinicalTrials.gov
public full text
Public Domain
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk#811316
- Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".#840810
- Advancing clinical precision medicine via peripheral blood immune single-cell omics.#309082
- Operating in a perceived ‘grey area' : an interpretive phenomenological study exploring elite athlete experiences of using prescribed asthma inhalers#824328
- Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients#909683
Record · ID 146328
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive